Can You Lose Weight Taking Ozempic? Clinical Evidence

Last reviewed: May 25, 2026

Last updated: May 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, clinical evidence demonstrates that GLP-1 receptor agonists like semaglutide can support weight loss in many individuals. The STEP clinical trials showed participants lost an average of 15-22% of baseline body weight over 68 weeks, significantly more than placebo.

However, outcomes vary widely among individuals due to genetic differences, metabolic factors, and lifestyle variables. Understanding your unique peptide genetic profile can help you and your provider evaluate whether this treatment approach aligns with your physiology and health goals.

How GLP-1 Medications Support Weight Loss Mechanisms

GLP-1 receptor agonists work by mimicking glucagon-like peptide-1, a hormone that regulates appetite and blood sugar. They signal satiety to your brain, reduce hunger hormone levels, and slow gastric emptying—the process by which food moves through your digestive system.

These combined effects typically result in reduced caloric intake without requiring conscious restriction. The medication addresses the neurobiological drivers of appetite rather than relying solely on willpower or dietary discipline.

Clinical Trial Data: Weight Loss Outcomes and Response Variability

Multiple randomized controlled trials have evaluated semaglutide efficacy. The STEP program enrolled over 4,500 participants across five trials, providing robust data on weight loss trajectories, side effect profiles, and factors associated with better or lesser response.

Trial Population / Finding	Weight Loss Range	Clinical Significance
STEP 1 (full program participation)	15-22% body weight	Superior to diet/exercise alone
STEP 2 (with T2DM diagnosis)	9-17% body weight	Additional glycemic benefit
STEP 3 (intensive behavioral intervention)	16-18% body weight	Combined approach value
Non-responders (15-20% of participants)	<5% body weight	Genetic/metabolic factors influence outcome

Genetic Variations That May Influence Individual Response

Your genetic makeup affects how your body responds to GLP-1 stimulation. Variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and FTO gene (rs9939609) influence appetite regulation, satiety signaling, and metabolic capacity for weight loss.

Individuals carrying specific genetic variants may experience different appetite suppression intensity, metabolic rate changes, or gastrointestinal side effect profiles. These predispositions do not determine outcomes but may provide context for personalizing your treatment approach with your provider.

Who Benefits Most: Eligibility, Safety, and Provider Guidance

GLP-1 medications are most appropriate for individuals with BMI ≥27 with weight-related comorbidities or BMI ≥30, though your provider evaluates individual medical history, medications, and contraindications. History of pancreatitis, thyroid cancer, or multiple endocrine neoplasia type 2 typically contraindicates use.

A qualified healthcare provider should assess your baseline health status, current medications, and treatment goals before initiating therapy. They can also interpret genetic testing results in context of your specific clinical picture and help you monitor for gastrointestinal side effects during titration.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context about your individual peptide pathway variations—including GLP1R, GIPR, FTO, and MC4R gene variants—that relate to appetite regulation and metabolic response. These insights can support a more personalized conversation with your healthcare provider about whether GLP-1 treatment aligns with your genetic predispositions.

The genetic test reveals predispositions in peptide signaling pathways, not exact medication response. Carrying genetic variants associated with stronger or weaker GLP-1 receptor sensitivity may influence your likelihood of robust appetite suppression or the intensity of side effects, but many other factors—lifestyle, adherence, concurrent medications, and overall health—also determine outcomes.

Understanding your genetic context allows you and your provider to set realistic expectations, choose appropriate dosing strategies, and plan monitoring protocols tailored to your physiology. This precision-wellness approach helps move beyond one-size-fits-all assumptions.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.